Novel biomarker SYT12 may contribute to predicting papillary thyroid cancer outcomes.

about

Novel biomarker SYT12 may contribute to predicting papillary thyroid cancer outcomes.

Item

http://www.wikidata.org/entity/Q47096509

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Novel biomarker SYT12 may contribute to predicting papillary thyroid cancer outcomes.

@en

Novel biomarker SYT12 may contribute to predicting papillary thyroid cancer outcomes.

@nl

type

Item

label

Novel biomarker SYT12 may contribute to predicting papillary thyroid cancer outcomes.

@en

Novel biomarker SYT12 may contribute to predicting papillary thyroid cancer outcomes.

@nl

prefLabel

Novel biomarker SYT12 may contribute to predicting papillary thyroid cancer outcomes.

@en

Novel biomarker SYT12 may contribute to predicting papillary thyroid cancer outcomes.

@nl

P1476

Novel biomarker SYT12 may contribute to predicting papillary thyroid cancer outcomes.

@en

P2093

D Liu

http://www.w3.org/2001/XMLSchema#string

E Felger

http://www.w3.org/2001/XMLSchema#string

J Jonklaas

http://www.w3.org/2001/XMLSchema#string

J Krishnan

http://www.w3.org/2001/XMLSchema#string

K D Burman

http://www.w3.org/2001/XMLSchema#string

L Boyle

http://www.w3.org/2001/XMLSchema#string

N Carrol

http://www.w3.org/2001/XMLSchema#string

Srk Murthy

http://www.w3.org/2001/XMLSchema#string

Y P Loh

http://www.w3.org/2001/XMLSchema#string

P2860

BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence

Cancer statistics, 2015

Integrated genomic characterization of papillary thyroid carcinoma

Thyroid hormone-responsive genes in developing cerebellum include a novel synaptotagmin and a hairless homolog

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

Molecular profiling related to poor prognosis in thyroid carcinoma. Combining gene expression data and biological information.

Long-Term Outcomes Following Therapy in Differentiated Thyroid Carcinoma: NTCTCS Registry Analysis 1987-2012

Expression profiles of pivotal microRNAs and targets in thyroid papillary carcinoma: an analysis of The Cancer Genome Atlas.

Reassessing the NTCTCS Staging Systems for Differentiated Thyroid Cancer, Including Age at Diagnosis.

A multi-gene approach to differentiate papillary thyroid carcinoma from benign lesions: gene selection using support vector machines with bootstrapping

P304

FSO249

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4155/FSOA-2017-0087

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Joanna Klubo-Gwiezdzinska

P577

2017-09-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29255621

http://www.w3.org/2001/XMLSchema#string

P932

5729603

http://www.w3.org/2001/XMLSchema#string